- Filed
- Aug 8, 2025 12:00 AM ET
- Period of report
- —
Amendment.
Amends a previously filed report.
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Jul 25, 2025 | 1.35B sh |
| Shares Diluted | Q1 2025 · Mar 31, 2025 | 910.37M sh |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 732.64M sh |
| Operating Cash Flow | Q1 2025 · Mar 31, 2025 | −$11.16K |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | −$37.54K |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $46.21K |
| Stockholders Equity restated | Q1 2025 · Mar 31, 2025 | −$962.89K |
| Stockholders Equity | Q1 2025 · Dec 31, 2024 | −$840.27K |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | −$705.84K |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | −$661.23K |
| Current Liabilities restated | Q1 2025 · Mar 31, 2025 | $1.01M |
| Total Liabilities restated | Q1 2025 · Mar 31, 2025 | $1.01M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $898.06K |
| Current Assets | Q1 2025 · Mar 31, 2025 | $46.21K |
| Current Assets | Q1 2025 · Dec 31, 2024 | $57.37K |
| Total Assets | Q1 2025 · Mar 31, 2025 | $46.21K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $57.79K |
| Eps Diluted | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2025 | $0.00 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | $0.00 |
| Net Income restated | Q1 2025 · Mar 31, 2025 | −$242.42K |
| Net Income | Q1 2025 · Mar 31, 2024 | −$44.61K |
| Operating Income | Q1 2025 · Mar 31, 2025 | −$43.54K |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$38.95K |
| Stock Issued | Q1 2025 · Mar 10, 2017 | 26.91M sh |